← SynDRA
ETILEVODOPA
SynDRA canonical compound SYN0027772 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | DDC | DRD3 |
|---|
| Mechanism of action | dopamine receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- DRD3 AGONIST
- Dopamine D3 receptor agonist
- dopamine receptor agonist
ATC classes
Cross-references
Synonyms
- levodopa ethyl ester
- L-dopa ethyl ester
- TV-1203
- LDEE
- ND-0601
- Levodopa-ethyl-ester
- Levodopa prodrug (transdermal, Parkinson's disease)
- Levodopa prodrug (transdermal, Parkinson's disease), NeuroDerm
- L-DOPA prodrug (transdermal, Parkinson's disease), NeuroDerm
- Levodopa ester, (transdermal, Parkinson's disease), NeuroDerm
- L-Dopa ethyl ester
- ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate
- O-Ethyl-DOPA
- etilevodopum
- RefChem:596832
- DTXCID601334195
- Levodopa ethyl ester
- MFCD00871210
- Ethyl (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate
- L-Tyrosine, 3-hydroxy-, ethyl ester
- (-)-3,4-Dihydroxy-L-phenylalanine, ethyl ester
- ethyl (2S)-2-amino-3-(34-dihydroxyphenyl)propanoate
- (S)-ETHYL 2-AMINO-3-(3,4-DIHYDROXYPHENYL)PROPANOATE
- Etilevodopa [USAN:INN]
- UNII-895X917GYE
- Etilevodopa?
- 3-hydroxy-L-tyrosine ethyl ester
- L-DOPA ethyl ester;Levodopa ethyl ester
- 3,4-Dihydroxy-L-phenylalanine ethyl ester
- ETILEVODOPA [INN]
- Etilevodopa (USAN/INN)
- ETILEVODOPA [USAN]
- ETILEVODOPA [WHO-DD]
- Ethyl 3-hydroxy-L-tyrosinate
- SCHEMBL584493
- orb1707323
- SCHEMBL29634876
- CHEBI:135971
Look up ETILEVODOPA in the interactive SynDRA portal →